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Abstract
Activation of the host antibacterial defenses by the toll-like receptors (TLR) also selectively activates energy-sensing and
metabolic pathways, but the mechanisms are poorly understood. This includes the metabolic and mitochondrial biogenesis
master co-activators, Ppargc1a (PGC-1a) and Ppargc1b (PGC-1b)i nStaphylococcus aureus (S. aureus) sepsis. The expression
of these genes in the liver is markedly attenuated inTLR2
2/2 mice and markedly accentuated in TLR4
2/2 mice compared
with wild type (WT) mice. We sought to explain this difference by using specific TLR-pathway knockout mice to test the
hypothesis that these co-activator genes are directly regulated through TLR2 signaling. By comparing their responses to S.
aureus with WT mice, we found that MyD88-deficient and MAL-deficient mice expressed hepatic Ppargc1a and Ppargc1b
normally, but that neither gene was activated in TRAM-deficient mice. Ppargc1a/b activation did not require NF-kb, but did
require an interferon response factor (IRF), because neither gene was activated in IRF-3/7 double-knockout mice in sepsis,
but both were activated normally in Unc93b1-deficient (3d) mice. Nuclear IRF-7 levels in TLR2
2/2 and TLR4
2/2 mice
decreased and increased respectively post-inoculation and IRF-7 DNA-binding at the Ppargc1a promoter was demonstrated
by chromatin immunoprecipitation. Also, a TLR2-TLR4-TRAM native hepatic protein complex was detected by
immunoprecipitation within 6 h of S. aureus inoculation that could support MyD88-independent signaling to Ppargc1a/b.
Overall, these findings disclose a novel MyD88-independent pathway in S. aureus sepsis that links TLR2 and TLR4 signaling
in innate immunity to Ppargc1a/b gene regulation in a critical metabolic organ, the liver, by means of TRAM, TRIF, and IRF-7.
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Introduction
TLR cell surface receptors that activate innate immunity form
specific dimers in response to conserved pathogen-associated
molecular patterns (PAMPs) [1]. In particular, TLR1-2 and
TLR2-6 heterodimers bind bacterial Gram-positive lipopeptides,
while TLR4 homodimers bind Gram-negative lipopolysaccharide
(LPS) [1]. All known TLRs, except TLR3, signal through the
MyD88 adaptor, and canonical TLR2 and TLR4 pathways
operate through MyD88 and MAL (TIRAP) to trigger pro-
inflammatory gene activation through NF-kB and mitogen-
activated protein kinases [2,3]. TLR2
2/2 cells show attenuated
cytokine responses to Gram-positive pathogens, such as S. aureus,
while MyD88
2/2 macrophages show no NF-kB-mediated TNF-a
and IL-6 production [4]. TLR3 activates TRIF (TICAM-1) and
TRAM (TICAM-2) to activate interferon response factors-3 and -
7 (IRF-3 and IRF-7) [5,6,7]. Some of these adaptor functions
overlap, and TLR2 and TLR4 may also signal non-canonically
through TRIF [8]. For instance, TLR2 responds to viral ligands
through TRIF to activate IRF-3/7 in a MyD88-independent
manner [9]. Also, TLR4 is activated by pathogenic S. aureus and
Gram-positive cell wall components [10,11,12,13,14,15,16].
Immune hyper-activation in sepsis produces metabolic stress,
e.g. from cytokine synthesis, fever, catecholamine release, NO
production, and changes in carbon substrate and oxygen
utilization [17]. In this setting, several energy-producing metabolic
and catabolic pathways are activated in response to the increased
cellular ATP and substrate requirements, but this also generates,
excessive reactive oxygen and nitrogen species, and this set of
conditions may promote mitochondrial damage and metabolic
dysregulation [18,19,20]. The energy-protective responses of the
cell also include mitochondrial biogenesis, which is initiated
through nuclear gene activation [21,22] controlled by ‘‘master’’
co-activator genes, e.g. the peroxisome proliferator-activated
receptor gamma co-activators, Ppargc1a, Ppargc1b, and Pprc
[23,24,25], whose protein products (PGC-1a PGC-1b and PRC)
partner with transcription factors that regulate and enhance
mitochondrial quality control [26]. PGC-1 is also critically
involved in lipid homeostasis and glucose metabolism [27,28],
especially in the liver, wherein heterozygosity of PGC-1a reduces
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6the level of gene expression, leading to impaired fatty acid
oxidation, steatosis, and insulin resistance [28]— the metabolic
hallmarks of sepsis.
Under the metabolic stress of S. aureus sepsis, Ppargc1a and
Ppargc1b are up-regulated synchronously, but independently of
Pprc. In peritonitis, Ppargc1a/Ppargc1b mRNA levels increase ,5-
fold in the liver in WT mice, but neither mRNA increases in
TLR2
2/2 mice, and both increase by 10–15-fold in TLR4
2/2
mice, in part through suppression of microRNA-mediated mRNA
degradation [29]. Of further interest, both Ppargc1 genes are up-
regulated in sepsis through an unknown cascade involving the
TLR2 and TLR4 signaling pathways. These findings led us to
postulate that S. aureus infected mice up-regulate Ppargc1a/Ppargc1b
through a unique arrangement of TLR2/TLR4 and adaptor
proteins that links innate immunity to cell metabolism and
mitochondrial biogenesis in the liver, a crucial metabolic and
immune organ.
Our findings indicate that hepatic Ppargc1a/Ppargc1b up-
regulation in S. aureus sepsis is independent of MyD88 and MAL
and does not require NF-kB, but relies instead on a novel TLR2
pathway involving TRAM, TRIF, and IRF-3/7. Studies of Ppargc1
regulation in Unc93b1
2/2 (3d) mice also indicate a lack of
involvement of nucleic acid sensing TLRs (TLR3, 7–9), and we
identify a post-inoculation interaction of TRAM with TLR2 and




S. aureus sepsis in mice produced by fibrin-clot implantation is
characterized by hepatic TLR2 and TLR4 up-regulation without
involvement of exogenous LPS [22,29]. The liver also demon-
strates an early up-regulation of the PGC-1 co-activator family of
genes, but Ppargc1a and Ppargc1b are not up-regulated in TLR2
2/2
mice and are amplified in TLR4
2/2 mice [29].




In order to check for appropriate cytokine responses to S. aureus,
we measured Tnf, Il6, and Il10 levels by Q-PCR in the liver in the
peritonitis model (Fig. 1). All three cytokines were up-regulated in
WT mice by 6 h PI, and declined towards baseline by 24 h.
TLR2
2/2 mice showed greater increases in all three cytokines
than WT mice at 6 h PI, but statistically only Tnf levels were
higher (WT Tnf 6 h PI: 8.0462.32; TLR2
2/2 Tnf 6 h PI:
27.51610.29; P,0.05). In contrast, TLR4
2/2 mice had
depressed cytokine up-regulation compared with WT, but
between the two strains only Tnf was statistically different at 6 h
PI (TLR4
2/2 Tnf 6 h PI: 0.6960.28; P,0.01 vs. WT). Since Tnf
production after S. aureus required TLR4, we checked LPS levels
by the Limulus assay and detected only 0.04 ng LPS per clot.
These abdominal clots undergo lysis over several days, so the mice
absorbed less than 0.04 ng of exogenous LPS each day.
NF-kB activation
The unexpected increase in NF-kB-related cytokine production
exhibited by TLR2
2/2 mice in response to S. aureus was evaluated
further in liver homogenates and nuclei from healthy control (HC),
WT, TLR2
2/2, and TLR4
2/2 mice. We checked NF-kB




2/2 mice (Fig. 2A). Nuclear p65 protein in WT mice was
comparable among HC mice and stable at 6 h PI, while HC
TLR2
2/2 and TLR4
2/2 mice had variable nuclear p65 levels pre-
infection (intra-experiment variability) and between-strain similarity
in nuclear p65 levels at 6 h PI. Thus, the p65 phosphorylation and
p65 nuclear patterns did not correspond. Nuclear p50 was detected
in similar amounts in the HC mice of the three strains and did not
Figure 1. Tnf, Il6, and Il10 mRNA expression. Hepatic mRNA levels
of Tnf (A), Il6 (B), and Il10 (C) were measured in WT, TLR2
2/2, and
TLR4
2/2 mice at 0 h (healthy control; HC), 6 h and 24 h PI in S. aureus
sepsis. For each strain, n$3 mice at each time point were compared
with HC of the same strain. * P,0.05, ** P,0.01; # indicates higher and
## lower values than WT. Vertical bars are SD.
doi:10.1371/journal.pone.0025249.g001
TLR2 Regulation of Ppargc1a/b
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mice, but increased in TLR4
2/2 and TLR2
2/2 mice. Thus, NF-
kB activation in the liver after S. aureus inoculation was variable in
the TLR-deficient strains and no pattern found that was consistent
with Pparg1a/b mRNA expression.
The role of NF-kBo nPpargc1a activation was examined after S.
aureus sepsis in two ways. WT mice were injected with an inhibitor
of IkB-a phosphorylation, BAY-11-7082 [30] at 20 mg/kg
[31,32], and then inoculated with S. aureus. IkB-a binds
preferentially to the p65 homodimer or to the p50–p65
heterodimer [33]; thus, BAY-treated mice showed no nuclear
translocation of p50/p65. NF-kB activity in S. aureus sepsis was
also evaluated in p50
2/2 mice (the p65 knockout is lethal) by Q-
PCR for Tnf mRNA compared with Ppargc1a mRNA. BAY-treated
mice had no increase in Tnf expression at 6 h PI (WT: 8.0-fold PI
vs. HC; BAY: 1.1-fold PI vs. HC; WT vs. BAY, P,0.01; Fig. 2B),
thus Tnf induction depended on p50/p65 activation. The p50
2/2
mice showed more variability in Tnf activity at 6 h PI (P=NS
compared to WT), but Tnf mRNA was still induced. Ppargc1a
mRNA was measured in BAY-treated WT and in p50
2/2 mice,
and neither experiment produced significantly different Ppargc1a
mRNA levels compared with controls (P=NS at 6 h PI). Thus,
Ppargc1a induction after S. aureus did not track TNF-a production
and was independent of classical NF-kB activation.
TLR-adaptor-deficient mice and S. aureus sepsis
To explore the mechanism of Ppargc1a/b gene induction,
MyD88
2/2 and MAL
2/2 mice were exposed to sepsis.
MyD88
2/2 mice do not activate NF-kB in response to S. aureus
due to the lack of the TLR2 adapter molecule [4,34,35]. In
MyD88
2/2 and MAL
2/2 mice, Ppargc1a and Ppargc1b mRNA
induction relative to HC mice were the same as for WT mice. At
6 h PI in MyD88
2/2 mice, Ppargc1a increased 8.5-fold vs. HC
(P,0.05), and Ppargc1b increased 5.5-fold vs. HC (P,0.01). In
MAL
2/2 mice, Ppargc1a increased 7.6-fold vs. HC (P,0.01), and
Ppargc1b increased 4.5-fold vs. HC (P,0.01) (Figs. 3A and 3B).
However, neither strain showed Tnf up-regulation comparable to
WT mice, which is consistent with impairment of NF-kB
activation (Fig. 3C). We concluded that hepatic Ppargc1a and
Ppargc1b are not under NF-kB control in S. aureus sepsis and are
regulated in a MyD88- and MAL-independent manner.
Since only four TLR adaptors are known, and the phenotype of
MAL
2/2 and MyD88
2/2 mice did not match the TLR2
2/2
mice, we considered the possibility that TLR2 could signal
through TRAM and/or TRIF to induce Ppargc1a/b expression.
We therefore exposed TRAM
2/2 mice and TRIF
2/2 mice to S.
aureus and found that they did not up-regulate Ppargc1a at 6 h PI
(TRAM
2/2: 1.1-fold and TRIF
2/2: 2.3-fold vs. HC, P=NS, and
P,0.05 compared to WT at 6 h for both) (Fig. 4A). TRAM
2/2
Figure 2. Nuclear p65, p50, and c-rel, and whole-cell phospho-p65. Immunoblots are shown for NF-kB family members in nuclear extracts
and in whole-liver extracts from WT, TLR2
2/2, and TLR4
2/2 mice in HC and at 6 h PI (A). Ppargc1a and Tnf mRNA levels in S. aureus sepsis (B).
Ppargc1a and Tnf mRNA levels at 6 h PI (compared to HC) were measured in WT, p50
2/2, and BAY-11-7082-treated mice (n=3 mice of each strain);
* P,0.01 compared with WT Tnf levels at 6 h PI. Vertical bars are SD.
doi:10.1371/journal.pone.0025249.g002
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2/2 mice showed
some Ppargc1b activation at 6 h PI, but this was much less than for
WT mice (TRAM
2/2: 0.7-fold vs. HC, P,0.05 compared to WT
at 6 h; TRIF
2/2: 2.8-fold vs. HC, P=NS compared to WT at
6h ,P,0.05 compared to HC) (Fig. 4B). This indicated that the
gene induction was dependent on TRAM and partly dependent
on TRIF. Neither TRAM
2/2 nor TRIF
2/2 mice showed a
significant difference in Tnf production compared with WT mice
(Fig. 4C). Thus, TLR2 signaling for Ppargc1a/b gene induction
operates through TRAM and TRIF because the absence of either
interferes with the response.
IRF-3 and IRF-7 activation and Ppargc1a transcription
The IRF-3 and IRF-7 transcription factors are the major known
effectors of TRAM and TRIF activity, and these were assayed in
WT and TLR2
2/2 mice. IRF-3 and IRF-7 are constitutive and
translocate to the nucleus upon activation [36,37]; however,
Figure 3. Ppargc1a, Ppargc1b, and Tnf mRNA levels in S. aureus
sepsis. Ppargc1a (A) and Ppargc1b (B) mRNA levels were measured in
WT, MyD88
2/2, and MAL
2/2 mice in healthy controls (HC) and at 6 h
and 24 h PI by Q-PCR, together with Tnf mRNA levels (C) at 6 h PI (fold-
induction compared to HCs; n$3 mice at each point for each strain);
* P,0.05, ** P,0.01 compared to HC of the same strain. Vertical bars
are SD.
doi:10.1371/journal.pone.0025249.g003
Figure 4. Ppargc1a, Ppargc1b, and Tnf mRNA levels in S. aureus
sepsis. Hepatic mRNA levels of (A) Ppargc1a and (B) Ppargc1b were
measured in WT, TRAM
2/2, and TRIF
2/2 mice in healthy controls (HC)
and at 6 h and 24 h PI by Q-PCR, compared with mRNA levels of (C) Tnf
at 6 h PI (fold-induction compared to HC; n$3 mice at each point for
each strain); * P,0.05 compared to HC of the same strain; #, P,0.05,
##, P,0.01 compared to WT data at 6 h. Bars are SD.
doi:10.1371/journal.pone.0025249.g004
TLR2 Regulation of Ppargc1a/b
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levels between HC mice and WT and TLR2
2/2 mice, but there
was a small increase in TLR4
2/2 mice at 6 h PI (Fig. 5A). In WT
mice, nuclear IRF-7 showed little change at 6 h PI followed by a
decline at 24 h PI, but TLR2
2/2 mice showed a markedly low
baseline level of nuclear IRF-7 and a further decrease at 6 h,
whereas TLR4
2/2 mice showed a marked increase in nuclear
IRF-7 at 6 h post-inoculation (Fig. 5B). Thus, nuclear IRF-7 levels
and nuclear IRF-7 translocation were deficient in TLR2
2/2 mice
and fit the pattern of Ppargc1a and Ppargc1b mRNA expression in
TLR2
2/2 [38] and in TRAM
2/2 and TRIF
2/2 mice.
The translation of Ppargc1a mRNA was checked by comparing
the expression levels of total PGC-1a protein in WT, TLR2
2/2,
and TLR4
2/2 mice after S. aureus inoculation (Fig. 5C). PGC-1a
was up-regulated in WT and TLR4
2/2 mice, but not inTLR2
2/2
mice. We also monitored mitochondrial levels of the fatty acid
oxidation enzyme, very long-chain specific acyl-CoA dehydroge-
nase (VLCAD), which is strongly regulated by PGC-1a. Hepatic
VLCAD levels decreased in WT and especially in TLR2
2/2 mice
in sepsis, but increased in TLR4
2/2 mice relative to the outer
membrane reference protein porin (Fig. 5D).
The Ppargc1a and Ppargc1b promoter regions were examined for
interferon-sensitive response elements (GAAANNGAAANN)
where IRF-3 and IRF-7 binding occurs [39] and sites were found
in both with close homology to the IRF-7 consensus. One Ppargc1a
site around 2289 Bp from the transcription start site (TSS) had a
conserved ISRE in mouse and human genes (Table S1). For this
site, we performed chromatin immunoprecipitation assays for
IRF-7 and found that it was active in WT mice, but not in
TLR2
2/2 mice (Fig. 5E). Positive (RNA Polymerase II and
transcription factor EF1a) and negative (negative IgG) controls




2/2 mice on a C57bl/6J background (IRF-3/
7 DKO) [40] were also tested in the S. aureus model. IRF-3/7
DKO mice did not induce Ppargc1a or Ppargc1b in the liver to
nearly the extent of WT mice (Figs. 6A and 6B). These data
further support TLR2 activation of a TRAM/TRIFRIRF-3/
7RPpargc1a/b response to S. aureus.
We performed functional rescue experiments of the TLR2
2/2
Ppargc1a/b phenotype in the S. aureus model. Since TLR3 activates
IRF-3 and IRF-7, we used polyinosinic-polycytidylic acid (polyI:C;
400 mg) [41], a dsRNA mimetic that activates TLR3 [42] for
Ppargc1a and Ppargc1b rescue in WT and TLR2
2/2 mice. The
polyI:C did not affect Ppargc1a/b mRNA levels in HC TLR2
2/2
mice (Fig. 6C); however, polyI:C in S. aureus inoculated TLR2
2/2
mice showed significant up-regulation of Ppargc1a at 6 h PI (4.23-
fold vs. HC, P,0.05). Because TLR3 activates IRF-3/7 through
TRIF, the polyI:C data indicated that IRF3/7 is necessary but not
sufficient for Ppargc1a induction in this model.
TLR2-TLR4 signaling
Since TLR2 ligands act mainly through MyD88, MyD88-
independent effects have drawn little further attention since the
original studies [7,43]. Macrophage and dendritic cells stimulated
with TLR2 ligands show no ISRE-binding activity or interferon-b
(IFN-b) up-regulation or IRF-3 translocation [6,44,45,46]. Howev-
er, viral particles do activate TRIF and IRF3/7 by TLR2
dimerization with TLR4, leading to TLR2-dependent TLR4
activation and signaling through TRIF and TRAM [9]. TLR-
integrin constructs also form TLR2/4 dimers [47], while comple-
mentation assays demonstrate cytoplasmic TLR2-TLR4 binding
[48]. In macrophages, damage-associated ligands, e.g. biglycan,
signal jointly through TLR2 and TLR4 [16,49]; reviewed in [50].
Using immunohistochemistry, we found that S. aureus inoculation
simultaneously and widely up-regulates both TLR2 and TLR4 by
6 h in WT mouse liver (Fig. 7A). To explore non-canonical TLR2
and TLR4 interactions in this setting, we compared the native
(complexed) and reduced states by Blue native PAGE [51,52] in
pre- and post-inoculation WT liver extracts prepared at 6 h PI in
0.5% n-dodecyl b-D-maltoside (DDM) without denaturing (no
DTT or heating), or in 4% sodium dodecyl sulfate (SDS) plus
Figure 5. Nuclear immunoblots for IRF-3 (A) and IRF-7 (B).
Immunoblots are shown for IRF-3 and IRF-7 in nuclear extracts from WT,
TLR2
2/2, and TLR4
2/2 mice in HC and at 6 h PI (One of duplicate
experiments with two mice per strain). (C) Immunoblots for PGC-1a
protein in WT, TLR2
2/2 and TLR4
2/2 mice at 0, 6, and 24 h after S
aureus inoculation. Equal protein loading was confirmed by Coomassie
blue staining. (D) Immunoblots for the mitochondrial VLCAD fatty acid
oxidation enzyme in HC and at 6 h PI in WT, TLR2
2/2, and TLR4
2/2
mice. Porin is a mitochondrial reference protein. (E) Chromatin
Immunoprecipitation. ChIP for IRF7 binding on the Ppargc1a promoter
at 2289 bp from TSS. WT and TLR2
2/2 mice (HC, 6 h PI, and 24 h PI)
were tested. Arrow shows the position of the binding. Pol II pull-downs
on EF1a are shown as loading controls.
doi:10.1371/journal.pone.0025249.g005
TLR2 Regulation of Ppargc1a/b
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dently blotted for TLR2, TLR4, and TRAM (Fig. 7B). In non-
denaturing conditions, each of the three antibodies independently
identified the same complex at ,300 kD.
We also exposed TLR2
2/26TLR4
2/2 mice to S. aureus, but in
three trials of paired mice, only two survived for 6 h and were
moribund, indicating that the inoculation stress was overly severe
in the absence of either TLR2 or TLR4. Since a TLR2/4
independent contribution to Ppargc1a/Ppargc1b induction had not
been excluded, we exposed Unc93b1-mutant (3d) mice (deficient in
TLR3, 7, 8 and 9 signaling) to S. aureus because the unc93b1
protein functions in ER trafficking and mediates translocation of
nucleotide-sensing TLRs from endoplasmic reticulum to endoly-
sosomes, allowing for their activation by microbial nucleic acids
[53,54]. This 3d mouse lacks endosome-dependent TLR signaling
and its responses signify a role for nucleotide-sensing TLRs in gene
activation. We measured Ppargc1a, Ppargc1b, Tnf, and Il10 mRNA
levels in Unc93b1
2/2 mice and found that all four genes responded
similarly to WT mice (Fig. 8), but there were trends towards more
Tnf and less Il10 activation at 6 h PI. Thus, TLR 3 or 7–9 do not
regulate Ppargc1a and Ppargc1b gene expression in S. aureus sepsis,
suggesting the TLR2/TLR4 balance is specifically involved in the
regulation of these genes.
Discussion
The key new finding is the existence of previously unsuspected
NF-kb-independent transcriptional cross-talk between hepatic
TLR2 and TLR4 and the Ppargc1a and Ppargc1b metabolic co-
activator genes. Metabolic dysfunction and organ failure are
common and potentially lethal problems in sepsis where pro-
survival energy-sensing pathways must be activated in concert with
the innate host defenses. Information on the regulation of energy-
sensing functions in this setting is limited, but the response is
controlled by an integrated transcriptional network that includes
NF-kb [55] and the mitochondrial damage response [56].
Mitochondrial DNA copy number falls in several organs in sepsis,
which puts oxidative phosphorylation at risk. The restoration of
mitochondrial density is delayed in TLR2 or TLR4 knockout mice
relative to WT controls [29].
As crucial co-activators of mitochondrial biogenesis [24,25], the
loss of Ppargc1a and Ppargc1b function results in a decline in
mitochondrial DNA copy number and ultimately in mitochondrial
dysfunction [57]. Specifically, in S. aureus infection, WT mice up-
regulate Ppargc1a and Ppargc1b, butTLR2
2/2 mice do not, while
TLR4
2/2 mice display much greater increases in these mRNA
levels than do WT mice. Our findings also indicate that these
metabolic co-activator genes are regulated by a novel MyD88-
independent mechanism.
TLR2 ligands rapidly activate NF-kB, so we first checked for
NF-kB regulation of Ppargc1a and Ppargc1b and found no evidence
for involvement of the classical pro-inflammatory NF-kB pathway.
TLR2
2/2 mice surprisingly showed higher and TLR4
2/2 mice
lower early-phase cytokine levels after S. aureus compared with WT
mice. Moreover, p50
2/2 and BAY-11-7082-treated mice exhib-
ited Ppargc1a up-regulation that was comparable to WT controls,
implying that NF-kB activation is not required. Moreover,
Ppargc1a/b is induced in MAL
2/2 and MyD88
2/2 mice after S.
aureus, even though both lacked NF-kB activation demonstrated by
weak Tnf expression.
Since Ppargc1a/b induction was not impaired in either MAL
2/2
or MyD88
2/2 mice, we tested TRAM
2/2 and TRIF
2/2 mice
and found, like the TLR2
2/2 mice, that neither strain induced
these genes [38]. The main downstream signal of TRAM/TRIF is
the phosphorylation of IRF-3 and IRF-7, and our data indicated
that nuclear IRF-7 increases in TLR4
2/2 and decreases in
TLR2
2/2 mice compared with WT mice, reflecting the levels of
Ppargc1 mRNA and the mitochondrial fatty acid oxidation enzyme
VLCAD.
The proximal promoter regions of Ppargc1a/b in the mouse and
human contain multiple partially-conserved ISRE sites, and by
Figure 6. Ppargc1a and Ppargc1b mRNA levels in S. aureus sepsis.
Hepatic levels of (A) Ppargc1a and (B) Ppargc1b mRNA were measured
in WT and IRF3/7
2/2 mice in healthy controls (HC) and at 6 h and 24 h
PI (n$3 at each point for each strain). (C) Ppargc1a mRNA levels after
PolyI:C treatment with or without S. aureus sepsis. Ppargc1a mRNA
levels were measured in WT and TLR2
2/2 mice in healthy controls (HC),
in mice dosed with 400 ug PolyI:C, and in mice given PolyI:C plus S.
aureus sepsis at 6 h and 24 h PI (n=3 mice at each point for each strain
*, P,0.05 compared to HC of the same strain; ##, P,0.05, #, P=0.08
compared to WT at 6 h). Vertical bars are SD.
doi:10.1371/journal.pone.0025249.g006
TLR2 Regulation of Ppargc1a/b
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double-knockout mice to S. aureus sepsis and saw impaired Ppargc1a/
b up-regulation, documenting a role for IRF-3/7. Using TLR3
agonist PolyI:C to induce IRF-7 in TLR2
2/2 mice, we found no
increase in basal Ppargc1a mRNA levels, but we did rescue the
Ppargc1a response in sepsis. Thus, other factors are also involved in
IRF-7 induction of Ppargc1a, e.g. similar to the type I interferon
response that follows TLR2 translocation to endolysosomes after
ligand engagement [58], though this response is not typical of S.
aureus sepsis. In any case, Ppargc1a induction in mice in response to S.
aureus infection clearly involves IRF-7, and the TRAM/TRI-
FRIRF-7RPpargc1a/b pathway represents a broadening of the
Figure 7. A. TLR2 and TLR4 localization in WT mouse liver by immunofluorescence microscopy. Representative paraffin sections were
stained for TLR2 in HC (top left) and 6 h PI (bottom left) and for TLR4 in HC (top right) and 6 h PI (bottom right). TLR staining is red; nuclear staining
with DAPI is blue. B. Blue native PAGE on whole liver extracts from WT mice at 6 h after inoculation with S. aureus. Each blot shows three lanes: Lane
1, NativeMark molecular weight standard; Lane 2, sample in 0.5% DDM with no DTT or heating; lane 3, sample in 4% SDS with 100 mM DTT, boiled at
95uC for 5 min. At the left, Coomassie staining of entire blot showing molecular markers. Western blots were performed with anti-TLR2, TLR4, or
TRAM. A complex near 300 kD was identified by all three primary antibodies (arrows) suggesting a possible interaction among the three proteins.
doi:10.1371/journal.pone.0025249.g007
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response.
Some intriguing differences in cytokine regulation were also
observed in WT, TLR2
2/2, and TLR4
2/2 mice, but these were
not pursued due to insufficient information on the membrane
proteins involved and the known discrepancies in vivo and in vitro
in response to live S. aureus and to Gram-positive cell wall
constituents, e.g. in TLR4
2/2 mice [10,11,12,13,14,15,16,29].
Because TLR4 does not bind Gram-positive ligands, a require-
ment for TLR4 in this in vivo study suggests the possibility that
endogenous ligands are involved in the induction of TLR2/TLR4
interactions that are not found in cell systems. For example, fibrin
breakdown products and physiological factors absent in cell
systems are present in peritonitis models, such as altered intestinal
epithelial barrier function, and generate additional DAMPs (e.g.
extracellular matrix products) or PAMPs (e.g. LPS translocation).
In this respect, the clot model mimics clinical peritonitis where
physical damage and deposition of hemoglobin and fibrin form a
bed for infection, and endogenous cell-surface or damage-receptor
ligands may contribute to the TLR2/4 interaction. Whatever
factors are responsible — microbial or host— TLR4 participates
in the defense against S. aureus. TLR4
2/2 mice show decreases in
S. aureus clearance and increases in mortality similar to TLR2
2/2
mice [11,29], and although Ppargc1a/b is essential for metabolic
gene expression and for mitochondrial biogenesis, these are not
the sole survival genes in the intact animal.
The formation of a TLR2-TLR4-TRAM complex may have
important implications for the host response to sepsis, but this
aspect is preliminary and there is insufficient data to propose a
definitive role for it the initiation of the hepatic response to S.
aureus inoculation. S. aureus rapidly up-regulates TLR2 and TLR4
in the mouse liver, and the use of weak non-ionizing detergent and
non-reducing conditions allows the detection of a native complex
that appears at a molecular weight ,60 kd higher than the
predicted triplex. This implies that one or more other factors, such
as post-translational modifications or adapter or chaperone
molecules, are involved. The establishment of a functional role
for a TLR2-TLR4 -TRAM complex would require cell studies
beyond the scope of this in vivo paper, and any such complex
could be unique to the liver [2–8]. There are multiple potential
TLR2 interactions that might explain both the known mitochon-
drial protective effects of TLR4 and the pronounced up-regulation
of the Ppargc1 metabolic co-activator genes observed here when
TLR4 is genetically deleted. Based on our findings, some
possibilities for TLR2-TLR4-TRAM interactions leading to
IRF7 activation are illustrated in Figure 9. The diagram puts
our findings into the context of the well-known TLR2 and TLR4
signaling pathways and outlines testable possibilities for TLR2-
dependent MyD88-independent IRF7 activation.
In any case, the TLR2-dependent regulation of Ppargc1a and
Ppargc1b through a MyD88-independent pathway has been
established, and this finding not only extends TLR2 signaling to
encompass key metabolic genes, but identifies distinct regulation of
the NF-kB-dependent pro-inflammatory genes and the hepatic
metabolic genes that maintain energy production and initiate
mitochondrial biogenesis after S. aureus infection. Although the
receptor signaling pathways will require detailed molecular and
cellular studies, the in vivo biology does suggest novel therapeutic
approaches. If Ppargc1a/b activation by IRF-7 translates to the
clinical setting, it should be possible to establish whether this
Figure 8. Ppargc1a, Ppargc1b, Il10, and Tnf mRNA levels in Unc93b1
2/2 mice. Hepatic mRNA levels of Ppargc1a, Ppargc1b, Il10, and Tnf were
measured in healthy controls (HC) and in S. aureus sepsis at 6 h PI in WT and Unc93b1
2/2 mice. There was no significant difference between
induction levels in WT and Unc93b1
2/2 mice for the four genes (n$3 mice at each point for each strain). Vertical bars are SD.
doi:10.1371/journal.pone.0025249.g008
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Ppargc1a and Ppargc1b expression increase functional mitochondrial
mass [24,25] and preserved mitochondrial function, e.g. in skeletal
muscle, is associated with better outcomes in sepsis [59]. Thus,
timed interventions to manipulate IRF-7 may improve cell
protection and hasten the resolution of multiple organ failure in
patients with sepsis and mitochondrial dysfunction.
Materials and Methods
Mouse Studies
The use of mice and the mouse protocols were pre-approved by
the Duke University Institutional Animal Care and Use Commit-
tee (#A208-10-08). Mice of either gender weighing 20–30 grams
were used for the studies. Studies were conducted in wild-type
(WT) C57Bl/6J mice obtained from Jackson Laboratories (Bar







2/2 mice obtained from Shizuo Akira,




were bred by the Paul Noble laboratory at Duke by crossing
TLR2
2/2 with TLR4
2/2 mice. The IRF3
2/26IRF7
2/2 mice
on the C57Bl/6J background was a kind gift of Dr. Michael
Diamond, Washington University St Louis [40]. The p50
2/2
mice on C57Bl/6J backgrounds were obtained from Jackson.
Unc93b1 mice were obtained from the Mutant Mouse Regional
Resource Center (Davis, CA) [53].
Mice were anesthetized with intraperitoneal xylazine and
ketamine, the abdomen shaved and cleaned with povidone-iodine,
and a midline laparotomy was performed. The peritoneum was
inoculated with a fibrin clot containing S. aureus and the incision
closed in two layers. Mice were resuscitated with 1 ml of
subcutaneous 0.9% NaCl. Healthy control (HC) mice of each
strain were also used. Mice were humanely killed at 6, 24, 48, or
72 h post-injury (PI) and the livers immediately harvested to
isolate mitochondria or snap-frozen and stored at 280uC.
For the clots, Staphylococcus aureus ssp aureus (ATCC) was
reconstituted and suspended in bovine fibrin [22]. The bacteria
were inoculated sterilely onto agar slants for 18 h and then re-
suspended to a concentration of 10
10 CFU/ml based on optical
Figure 9. Potential TLR signaling pathways for Ppargc1 metabolic co-activator gene activation after S. aureus infection. Pathway 1
shows the canonical TLR2 MyD88-dependent signaling pathway that activates NF-kB after S. aureus. Pathway 2 shows TLR4 MyD88-dependent
signaling to NF-kB and MyD88–independent signaling to TRIF/TRAM. Both MyD88 pathways have been excluded as causes of the Ppargc1a gene
expression. Pathway 3 shows a putative TLR2-TLR4 heterodimer interacting with TRIF/TRAM. Pathway 4 indicates TLR2 in the TLR4 null state, as a
homodimer or a heterodimer involving a non-TLR4 partner such as TLR1 or 6, interacting with TRIF/TRAM and unmasking the innate immune
regulation of Ppargc1a expression. Pathway 5 shows canonical TLR3 endosome signaling also excluded in Ppargc1 gene regulation after S. aureus;
however, independent TLR3 activation partially rescues the Ppargc1 phenotype in mice. TIRAP is Toll/interleukin-1 receptor domain-containing
adapter protein (MAL); IRAK4 is Interleukin-1 receptor-associated kinase 4; TRAF3 and TRAF6 are TNF receptor-associated factor 3 and 6; TAK1 is TGF-
beta-activated kinase 1 and TBK1 is NF-kappa-B-activating kinase.
doi:10.1371/journal.pone.0025249.g009
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5,1 0
6,o r1 0
7 CFU were then
suspended in 500 ml fibrin clots (500 ml of 10 mg/ml bovine
fibrinogen, fraction 1, plus 10 ml of bovine plasma thrombin)
(Sigma, St Louis, MO). Pour plates were used to confirm microbial
counts. The Limulus Amebocyte Lysate (LAL) assay was performed
with a GenScript Chromogenic LAL endotoxin assay kit (Gen-
Script, Piscataway, NJ). Thrombin and fibrinogen were prepared in
the standard fashion and tested in duplicate for endotoxin.
Real-Time RT-PCR
RNA was extracted with TRIzol reagent (Invitrogen, Oslo,
Norway) and reverse transcribed with the ImProm-II Reverse
Transcription System (Promega, Madison, WI). Mouse-specific
primers were designed or purchased from Applied Biosystems
(Table 1) and real-time PCR carried out in triplicate, using 18 s
primers as internal controls [56]. Real-time PCR output for HC
mice of each strain was set to one, and relative quotients obtained
at the later time points.
Nuclear Isolation
Fresh liver was homogenized in a nuclear buffer (0.32 M
sucrose, 3 mM MgCl2, 2 mM DTT, 20 mM K-HEPES, pH 7.2,
plus 1 mM Na-ascorbate and 1:100 fresh Sigma Protease Inhibitor
Cocktail, Phosphatase Inhibitor Cocktail 1 and Phosphatase
Inhibitor Cocktail 2) (Sigma, St Louis, MO). The homogenate
was twice-filtered through cheese cloth and centrifuged at 3,8006g
for 20 min at 4uC. The supernatant was discarded and the pellet
re-suspended in 1.0 ml isolation buffer (2 M sucrose, 1 mM
MgCl2, 2 mM DTT, 5 mM K-HEPES (pH 7.2)). This suspension
was poured over 2.0 ml of isolation buffer and centrifuged at
113,0006g for 1 h at 4uC. The supernatant was decanted and the
pellet re-suspended in 150 mM KCl, 5 mM MgCl2,5 m M
HEPES buffer at pH 7.2. This suspension was spun at 5006g
for 20 min at 4uC, and the pellet was fixed for ChIP analysis or
frozen at 280uC in RIPA buffer (150 mM NaCl, 1 mM EDTA,
50 mM Tris-HCl (pH 7.4), 1% Igepal, 0.25% deoxycholate, plus
1:100 fresh Protease Inhibitor Cocktail, Phosphatase Inhibitor
Cocktail 1 and Phosphatase Inhibitor Cocktail 2, and 1 mM
PMSF). Nuclear extractions were confirmed by immunoblots for
His3 (positive) and LDH (negative) (Santa Cruz Biotechnology,
Santa Cruz, CA).
Western Blots
Whole cell extracts or nuclei were sonicated and standardized
for protein using bicinchoninic acid. Proteins were resolved by
sodium dodecyl sulfate-PAGE on 4–20% gels and transferred to
PDVF membranes. Membranes were probed with affinity-purified
primary antibodies (Table 1) and exposed to the appropriate
Table 1. Antibodies and Primers.
Protein Host Company Catalog #
IRF3 Rabbit Santa Cruz 9082
p-IRF3 Rabbit Cell Signaling 4947
IRF7 Mouse Santa Cruz 74472
IRF7 Mouse Novus Biologicals NBP1-04309
LDH Goat Santa Cruz 27230
MyD88 Rabbit Santa Cruz 11356
NF-kB p50 Rabbit Santa Cruz 7178
NF-kB p65 Rabbit Santa Cruz 372
TICAM-2 (TRAM) Rabbit Santa Cruz 67061
TLR2 Rabbit Cell Signaling 2229
TLR2 Rabbit Santa Cruz 10739
TLR2 Rabbit Rockland 600-401-956
TLR4 Mouse Imgenex IMG-5031A
PGC-1a Rabbit Cayman 101707
VLCAD Mouse MitoSciences MS707
ChIP Probes Site Forward Primer Reverse Primer
IRF7 on PGC-1b 2467 Bp (from TSS) CCTCCCTCTCTGGCCTTGCTG GGGAGGCTTAGAGCCGCTT
IRF7 on PGC-1a 22395 Bp AGGGCAGCGTGTCTGTGTTCA GCTCACACTGAATTGTGGCAGG
IRF7 on PGC-1a 2221 Bp CAAAGCTGGCTTCAGTCACA TTGCTGCACAAACTCCTGAC
18S NR_003278.1 AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA
Applied Biosystems Assay # Gene Region Amplicon Length (Bp)
TNF-a NM_013693.2 mm99999068 Exons 3–4, nt 448 (63)
IL-6 NM_031168.1 mm00446190 Exons 2–3, nt 236 (78)
IL-10 NM_010548.1 mm00439616 Exons 3–4, nt 452 (85)
PGC-1a (Pargc1a) NM_008904.2 mm00447187 Exons 9–10, nt 2072 (82)
PGC-1b (Ppargc1b) NM_133249.2 mm01258518 Exons 9–10, nt 2732 (83)
doi:10.1371/journal.pone.0025249.t001
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with ECL (Santa Cruz) and imaged on X-ray film in the mid-
dynamic range. Membranes were stained with Coomassie blue as
a loading control. The blots were quantified on a BioRad G-710
densitometer.
Tissue Immunofluorescence
Livers were fixed in 4% paraformaldehyde, dehydrated,
paraffin-embedded, and cut into 4–5 micron sections. After
antigen retrieval, the slides were stained with primary TLR2 or
TLR4 antibody (SC-52735, mouse monoclonal, and SC-10741,
rabbit polyclonal, Santa Cruz), a fluorescently-labeled secondary,
and counterstained with DAPI. Confocal images were collected in
fluorescence mode followed by electronic image merging.
Chromatin Immunoprecipitation
Nuclear extracts were exposed to 1% formaldehyde for 15 min
at 24uC, and the reaction quenched in 0.125 M glycine for 5 min.
DNA was sheared with a sonicator into ,200–800 bp fragments.
ChIP was carried out using the ChIP-IT Express Kit (Active
Motif, Carlsbad, CA) and the manufacturer’s instructions using
mouse monoclonal anti-IRF-7 and rabbit polyclonal anti-Pol-II
(Santa Cruz Biotechnology). Primers were designed for the ISRE
sequence for IRF-7 in the Ppargc1a promoter and the promoter of
EF1a (for Pol-II). Conventional PCR was carried out to 40 cycles
at 60uC.
Blue Native PAGE
Snap-frozen liver from WT mice was homogenized in Native
PAGE bis-tris buffer (Invitrogen) with either 0.5% DDM or 4%
SDS. The lysates were centrifuged at 14,0006g for 20 min, and
supernatant protein content measured. DTT was added to a final
concentration of 100 mM, and the samples boiled for 5 min at
95uC. The samples were mixed 1:1 with Blue Native running
buffer from the NativePAGE
TM NovexH Bis-TrisGel System
(Invitrogen), and run on 3–12% bis-tris polyacrylamide gels with
NativeMark unstained molecular weight standards (Invitrogen).
Gels were transferred to PVDF and washed twice in methanol to
remove excess Coomassie blue before immunoblotting.
Statistics
Grouped data are presented as means 6 SD. The n values in
the experiments are for the total number of mice of each strain.
Each point in the real-time PCR experiments was compared to the
healthy control (HC) of its own strain using the Student’s t-test.
The 6 h between strain points were compared with Student’s t-
tests with adjustment for multiple comparisons where necessary.
The statistical significance levels (P) are provided with the Results.
Supporting Information
Table S1 Mouse (Mm) Ppargc1a and human (Hs)
PPARGC1A promoter alignment. ChIP primer sites and the
IRF7 consensus sequence for the mouse are indicated. TSS=tran-
scription start site. Note the presence of expanded ISREs in the Hs
promoter around the same site.
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